BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37095509)

  • 1. Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17.
    Chan YJ; Hsiao G; Wan WN; Yang TM; Tsai CH; Kang JJ; Lee YC; Fang TC; Cheng YW; Li CH
    Fluids Barriers CNS; 2023 Apr; 20(1):31. PubMed ID: 37095509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titanium dioxide nanoparticles impair the inner blood-retinal barrier and retinal electrophysiology through rapid ADAM17 activation and claudin-5 degradation.
    Chan YJ; Liao PL; Tsai CH; Cheng YW; Lin FL; Ho JD; Chen CY; Li CH
    Part Fibre Toxicol; 2021 Jan; 18(1):4. PubMed ID: 33422125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.
    Roudnicky F; Zhang JD; Kim BK; Pandya NJ; Lan Y; Sach-Peltason L; Ragelle H; Strassburger P; Gruener S; Lazendic M; Uhles S; Revelant F; Eidam O; Sturm G; Kueppers V; Christensen K; Goldstein LD; Tzouros M; Banfai B; Modrusan Z; Graf M; Patsch C; Burcin M; Meyer CA; Westenskow PD; Cowan CA
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19854-19865. PubMed ID: 32759214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions.
    Yan Z; Wang C; Meng Z; Gan L; Guo R; Liu J; Bond Lau W; Xie D; Zhao J; Lopez BL; Christopher TA; Naik UP; Ma X; Wang Y
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269401
    [No Abstract]   [Full Text] [Related]  

  • 5. Inner Blood-Retinal Barrier Regulation in Retinopathies.
    Hudson N; Campbell M
    Adv Exp Med Biol; 2019; 1185():329-333. PubMed ID: 31884633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy.
    Hudson N; Celkova L; Hopkins A; Greene C; Storti F; Ozaki E; Fahey E; Theodoropoulou S; Kenna PF; Humphries MM; Curtis AM; Demmons E; Browne A; Liddie S; Lawrence MS; Grimm C; Cahill MT; Humphries P; Doyle SL; Campbell M
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericytes of Indirect Contact Coculture Decrease Integrity of Inner Blood-Retina Barrier Model
    Yang T; Guo L; Fang Y; Liang M; Zheng Y; Pan M; Meng C; Liu G
    Dis Markers; 2021; 2021():7124835. PubMed ID: 34630739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia increase tight-junction permeability in coordination with Müller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier.
    Inada M; Xu H; Takeuchi M; Ito M; Chen M
    Exp Eye Res; 2021 Apr; 205():108490. PubMed ID: 33607076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-selective and in vitro assessment of inner blood retina barrier permeability.
    Campbell M; Humphries P
    Methods Mol Biol; 2011; 763():355-67. PubMed ID: 21874464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
    Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
    Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disheveled-1 Interacts with Claudin-5 and Contributes to Norrin-Induced Endothelial Barrier Restoration.
    Díaz-Coránguez M; González-González L; Wang A; Liu X; Antonetti DA
    Cells; 2023 Oct; 12(19):. PubMed ID: 37830616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
    Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
    Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage.
    Vázquez-Liébanas E; Mocci G; Li W; Laviña B; Reddy A; O'Connor C; Hudson N; Elbeck Z; Nikoloudis I; Gaengel K; Vanlandewijck M; Campbell M; Betsholtz C; Mäe MA
    Cell Rep; 2024 Mar; 43(3):113911. PubMed ID: 38446668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-retina barrier: tight junctions and barrier modulation.
    Campbell M; Humphries P
    Adv Exp Med Biol; 2012; 763():70-84. PubMed ID: 23397619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability.
    Liao Z; Yang Z; Piontek A; Eichner M; Krause G; Li L; Piontek J; Zhang J
    Neuroscience; 2016 Jul; 327():53-63. PubMed ID: 27095710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury.
    Abcouwer SF; Shanmugam S; Muthusamy A; Lin CM; Kong D; Hager H; Liu X; Antonetti DA
    J Neuroinflammation; 2021 Aug; 18(1):186. PubMed ID: 34446062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
    Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
    Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy.
    Campbell M; Nguyen AT; Kiang AS; Tam L; Kenna PF; Dhubhghaill SN; Humphries M; Farrar GJ; Humphries P
    Adv Exp Med Biol; 2010; 664():301-8. PubMed ID: 20238029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.